All human and mice ORF clones and related Lentivirus, AAV particles and recombinant proteins provided by GeneCopoeia are fully sequenced using Sanger sequencing by capillary electrophoresis and Amino Acid Sequences are guaranteed to be matched with NCBI database.

EndoFectin™ RNAi Transfection Reagent

*Promotions are valid in the US & Canada only. For international customers, please contact your local distributors. Promotion ends July 31, 2025. Discounts are not valid on previous purchases and cannot be combined with additional discounts.

Products

EndoFectin™ RNAi

EndoFectin™ RNAi transfection reagent is a transfection reagent based on the principle of lipofectamine® transfection. It is specially designed to deliver siRNA and miRNA to mammalian cells. It can form a complex with nucleic acid and allow the complex to enter the cell. EndoFectin™ RNAi transfection reagent is widely applicable to common cell lines, such as HEK-293, HEK293T, Hela, NIH/3T3 and A549, etc. This reagent efficiently delivers nucleic acids into cells even in the presence of serum.

Advantages

Better transfection efficiency.
Low cytotoxicity.
For transfection of a variety of cell lines, easy to operate.
Does not require removal of serum or culture medium, or removal of medium after transfection.

Buy	Catalog #	Product	Price (US$)	Protocol	MSDS
	EF021	EndoFectin™ RNAi transfection reagent (1 mL)	$307	Download	Download
	EF022	EndoFectin™ RNAi transfection reagent (3 mL)	$613	Download	Download

Comparison of EndoFectin™ RNAi and Lipofectamine® 2000 in the siRNA transfection efficiency

Figure 1. EndoFectin™ RNAi and Lipofectamine®2000 transfection reagent were used to transfect 5 pmol and 10 pmol FAM-labeled β-actin-siRNA into HEK293T (A), Hela (B), and A549 (C). After 6 hours, the FAM green fluorescence intensity was observed through a fluorescence microscope.

Comparison of EndoFectin™ RNAi and Lipofectamine®3000 on eGFP gene in the knockdown effects

Figure 2. Use 1 μL EndoFectin™ RNAi and Lipofectamine®3000 transfection reagent respectively to transfect 5 pmol eGFP-siRNA into the Hela-eGFP stable cell line (cat#. SL040) in a 24-well plate. After 48 hours, changes in eGFP fluorescence intensity were observed through a fluorescence microscope.

Comparison of EndoFectin™ RNAi and Lipofectamine® RNAiMAX on eGFP gene in the knockdown effects

Figure 3. Use 1 μL EndoFectin™ RNAi and Lipofectamine® RNAiMAX transfection reagent respectively to transfect 5 pmol eGFP-siRNA into the HEK293T-eGFP stable cell line (cat#. SL039) in a 24-well plate. After 72 hours, changes in eGFP fluorescence intensity were observed through a fluorescence microscope.